Minimizing and Managing Toxicities to Maintain Patients on BTK Inhibitor Therapy

Help keep your patients on BTK inhibitor treatment with this online AE management tool supported by an expert commentary and a downloadable resource for clinicians to discuss with patients.

Share

Program Content

No activities added yet

No activities added yet

Supporters

Supported by educational grants from

AstraZeneca

Janssen administered by Scientific Affairs

Pharmacyclics an AbbVie Company